Six hundred and ninety-two cases of kala-azar were studied, all confirmed cases. Vaishali, Muzaffarpur, Samsatipur and Sitamarhi were the most affected districts of Bihar. Fever, weight loss, hepatosplenomegaly, anaemia, leucopenia and monocytes were the most commonly found features, whereas pigmentation of skin was found in only 4.48% of cases. Lymphadenopathy and voracious appetite were conspicious by their absence. Study of the incubation period of the disease showed that it may be as short as 24 h. Bone marrow study revealed hypoplastic marrow with increase in the cells of the monocytic series. Serum electrophoresis revealed reduction in albumin and rise in globulin, leading to decrease in A : G ratio. Tuberculin test was negative in the majority of the patients.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Identification of new potential inhibitors of pteridine reductase-1 (PTR1) via biophysical and biochemical mechanism-based approaches: Step towards the treatment of Leishmaniasis.
Int J Biol Macromol
December 2024
H.E.J. Research Institute of Chemistry, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan; Dr. Panjwani Center for Molecular and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Pakistan. Electronic address:
Leishmaniasis is a parasitic disease, which spreads from the bite of an infected Phlebotomine fly to human hosts. The disease is characterized by a number of clinical manifestations, such as ulcerative lesions at the site of sandfly bite (cutaneous form), inflammation of mucosal membranes (mucosal leishmaniasis) or the deadly visceral form. This study was aimed to target pteridine reductase-1 (PTR1), a member of short chain dehydrogenases, which accounts for the reduction of conjugated and unconjugated pterins in Leishmania parasite.
View Article and Find Full Text PDFInvestigation of potential ascorbate peroxidase inhibitors for anti-leishmaniasis therapy.
Folia Microbiol (Praha)
August 2024
Department of Clinical Laboratory Sciences, Faculty of Applied Medical Sciences, Najran University, Najran, Saudi Arabia, 61,441.
Article Synopsis
- - Leishmaniasis affects 98 countries, primarily causing severe illness and death, especially in its visceral form, necessitating the development of better treatments due to ineffective current options and side effects of existing drugs.
- - A study identified nine natural compounds that inhibit the APX enzyme in Leishmania donovani, with estradiol cypionate showing the strongest binding affinity, indicating potential for effective treatment.
- - The compounds exhibited favorable drug-like properties, suggesting they could lead to novel oral treatments for leishmaniasis and warrant further research into their therapeutic potential.
Rational repurposing, synthesis, and studies of chromone-peptidyl hybrids as potential agents against .
J Enzyme Inhib Med Chem
December 2023
Medicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, Republic of Korea.
A chromone-peptidyl hybrids series was synthesised and rationally repurposed towards identification of potential antileishmanial hits against visceral leishmaniasis. Three hybrids , , and showed potential IC values (9.8, 10, and 12 µM, respectively) which were comparable to erufosine IC (9.
View Article and Find Full Text PDFBestatin analogs-4-quinolinone hybrids as antileishmanial hits: Design, repurposing rational, synthesis, in vitro and in silico studies.
Eur J Med Chem
March 2023
Medicinal Chemistry Laboratory, Department of Pharmacy, College of Pharmacy, Kyung Hee University, Seoul, 02447, Republic of Korea; Department of Fundamental Pharmaceutical Sciences, Kyung Hee University, Seoul, 02447, Republic of Korea. Electronic address:
Amongst different forms of leishmaniasis, visceral leishmaniasis caused by L. donovani is highly mortal. Identification of new hit compounds might afford new starting points to develop novel therapeutics.
View Article and Find Full Text PDFMolecular Modeling, Virtual Screening, and Molecular Dynamics for Methionyl-tRNA Synthetase.
J Phys Chem B
December 2022
Laboratory of Medicinal and Computational Chemistry (LQMC), Center for Research and Innovation in Biodiversity and Drug Discovery (CIBFar), Institute of Physics of São Carlos, University of São Paulo (USP), Av. João Dagnone, no. 1100, São Carlos, SP 13563-120, Brazil.
Visceral leishmaniasis is a neglected tropical disease (NTD) caused by and that is lethal in cases of nontreatment. The treatments are limited by serious drawbacks involving safety, resistance, stability, and high costs. In this work, we aimed to identify inhibitors of methionyl-tRNA synthetase (MetRS), a validated molecular target for leishmaniasis drug discovery, using a combination of strategies.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!